Morphiceptin
![]() | |
Names | |
---|---|
IUPAC name
(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide[1] | |
Other names
Tyr-Pro-Phe-Pro-NH2, PLO17 | |
Identifiers | |
87777-29-5 ![]() | |
ChemSpider | 106565 ![]() |
Jmol interactive 3D | Image |
PubChem | 119303 |
| |
| |
Properties | |
C28H35N5O5 | |
Molar mass | 521.6 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
![]() ![]() ![]() | |
Infobox references | |
Morphiceptin is a tetrapeptide (Tyr-Pro-Phe-Pro-NH2) that is a selective μ-opioid receptor agonist. It is derived from β-casomorphin and has over 1,000 times selectivity for μ- over δ-opioid receptors. When injected intracerebroventricularly (into the ventricular system of the brain), morphiceptin had an analgesic ED50 of 1.7 nmol per animal. The analgesic effects of morphiceptin were reversed by naloxone, meaning that the analgesic effect is mediated by the μ-opioid receptor.[2]
See also
References
- ↑ "Morphiceptin". Morphiceptin. ChemBase. Retrieved 1 August 2011.
- ↑ Chang, K (3 May 1982). "Analgesic activity of intracerebroventricular administration of morphiceptin and β-casomorphins: Correlation with the morphine (μ) receptor binding affinity". Life Sciences 30 (18): 1547–1551. doi:10.1016/0024-3205(82)90242-9.
This article is issued from Wikipedia - version of the Tuesday, July 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.